We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CannabisNewsWire Editorial Coverage: Relatively insulated from economic cycles, the innovation of today’s biotech companies puts them in a position to potentially deliver outsized returns...
NetworkNewsWire Editorial Coverage: The discovery of the human body’s endocannabinoid system in the early 1990s led to a surge of new drug development activity to address multiple maladies and...
NetworkNewsWire Editorial Coverage: As more Canadians than ever suffer chronic pain, the chase is on to find novel therapeutic approaches to effectively manage their conditions. In fact, BMC...
Vancouver, BC -- October 23, 2017 -- InvestorsHub NewsWire -- Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a...
October 17, 2017 -- Vancouver, BC -- InvestorsHub NewsWire -- Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a...
October 17, 2017 - Vancouver, BC - InvestorsHub NewsWire - Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the "Company" or "Isodiol"), a global Bioactive Phytoceutical...
October 13, 2017 -- Vancouver, BC -- InvestorsHub Newswire -- Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a...
October 4, 2017 - Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive...
September 5th, 2017 -- Vancouver, BC -- InvestorsHub Newswire -- Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a...
August 30th, 2017 -- Vancouver, BC -- InvestorsHub NewsWire -- Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
4 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
12 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
26 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
52 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
156 | 0 | 0 | 0.035 | 0.035 | 0.035 | 0 | 0 | CS |
260 | -0.14 | -80 | 0.175 | 0.38 | 0.02 | 79773 | 0.06234885 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions